Response to traditional disease-modifying anti-rheumatic drugs in indigent South Africans with early rheumatoid arthritis

Clinical Rheumatology

Volumn 31, Issue 4, 2012, Pages 613-619

  Hodkinson, B ^a   Musenge, E ^b   Ally, M ^c   Meyer, P W A ^d   Anderson, R ^d,e   Tikly, M ^a  

^a UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^b UNIVERSITY OF THE WITWATERSRAND   (South Africa)

^c UNIVERSITY OF PRETORIA   (South Africa)

^d UNIVERSITY OF PRETORIA   (South Africa)

^e Service Tshwane Academic Division   (South Africa)

Author keywords

Anaemia; DMARDs; Response to therapy; Rheumatoid arthritis; South Africa

Indexed keywords

AUTOANTIBODY; CHLOROQUINE; HEMOGLOBIN; METHOTREXATE; PREDNISONE; SALAZOSULFAPYRIDINE;

ADULT; AGGRESSION; AREA UNDER THE CURVE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DEMOGRAPHY; DISEASE ACTIVITY; DISEASE CONTROL; DRUG DOSE INCREASE; DRUG RESPONSE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HEMOGLOBIN BLOOD LEVEL; HUMAN; INDIGENT; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MEDICAL EDUCATION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RADIOGRAPHY; RECEIVER OPERATING CHARACTERISTIC; RHEUMATOID ARTHRITIS; SOUTH AFRICA;

ADULT; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CHLOROQUINE; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; MALE; METHOTREXATE; MIDDLE AGED; POVERTY; PREDNISONE; SEVERITY OF ILLNESS INDEX; SOUTH AFRICA; SULFASALAZINE; TREATMENT OUTCOME; UNCOMPENSATED CARE;

EID: 84859752405     PISSN: 07703198     EISSN: 14349949     Source Type: Journal    
DOI: 10.1007/s10067-011-1900-5     Document Type: Article

References (30)

1. Smolen JS, Aletaha D, Machold KP (2005) Therapeutic strategies in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:163-177 (Pubitemid 40003947)
2. Quinn MA, Cox S (2005) The evidence for early intervention. Rheum Dis Clin North Am 31:575-589 (Pubitemid 41608443)
3. Morel J, Combe B (2005) How to predict prognosis in early rheumatoid arthritis. Best Pract Res Clin Rheumatol 19:137-146 (Pubitemid 40003945)
4. Mayosi BM, Flisher AJ, Lalloo UG et al (2009) The burden of non-communicable diseases in South Africa. Lancet 374:934-947
5. Beaglehole R, Bonita R, Horton R et al (2011) Priority actions for the non-communicable disease crisis. Lancet 377:1438-1447
6. Tikly M, Zannettou N, Hopley M (2003) A longitudinal study of rheumatoid arthritis in South Africans. MedGenMed 5:2
7. Solomon A, Christian BF, Dessein PH et al (2005) The need for tighter rheumatoid arthritis control in a South African public health care center. Semin Arthritis Rheum 35:122-131 (Pubitemid 41356588)
8. Arnett FC, Edworthy SM, Bloch DA et al (1988) The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 31:315-324 (Pubitemid 18091653)
9. Kirwan JR, Reeback JS (1986) Stanford Health Assessment Questionnaire modified to assess disability in British patients with rheumatoid arthritis. Br J Rheumatol 25:206-209 (Pubitemid 16033804)
10. Organisation WH (1968) Nutritional anaemias: report of a WHO Scientific Group. World Health Organ Tech Rep Ser 405:5-37
11. Aletaha D, Smolen J (2005) The Simplified Disease Activity Index (SDAI) and the Clinical Disease Activity Index (CDAI): a review of their usefulness and validity in rheumatoid arthritis. Clin Exp Rheumatol 23:S100-S108 (Pubitemid 46657517)
12. Rau R, Herborn G (1995) A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 22:1976-1982
13. Saevarsdottir S, Wallin H, Seddighzadeh M et al (2011) Predictors of response to methotrexate in early DMARD naive rheumatoid arthritis: results from the initial open-label phase of the SWEFOT trial. Ann Rheum Dis 70:469-475
14. Khanna D, Oh M, Furst DE et al (2007) Evaluation of the preliminary definitions of minimal disease activity and remission in an early seropositive rheumatoid arthritis cohort. Arthritis Rheum 57:440-447 (Pubitemid 46682531)
15. Harrison MJ, Tricker KJ, Davies L et al (2005) The relationship between social deprivation, disease outcome measures, and response to treatment in patients with stable, long-standing rheumatoid arthritis. J Rheumatol 32:2330-2336
16. Vliet Vlieland TP, Buitenhuis NA, van Zeben D (1994) Sociodemographic factors and the outcome of rheumatoid arthritis in young women. Ann Rheum Dis 53:803-806
17. Sokka T, Kautiainen H, Toloza S et al (2007) QUEST-RA: quantitative clinical assessment of patients with rheumatoid arthritis seen in standard rheumatology care in 15 countries. Ann Rheum Dis 66:1491-1496 (Pubitemid 350032658)
18. Drossaers-Bakker KW, Zwinderman AH, Vliet Vlieland TP et al (2002) Long-term outcome in rheumatoid arthritis: a simple algorithm of baseline parameters can predict radiographic damage, disability, and disease course at 12-year followup. Arthritis Rheum 47:383-390 (Pubitemid 34856126)
19. Gossec L, Dougados M, Goupille P et al (2004) Prognostic factors for remission in early rheumatoid arthritis: a multiparameter prospective study. Ann Rheum Dis 63:675-680 (Pubitemid 38658397)
20. Furst DE, Chang H, Greenberg JD et al (2009) Prevalence of low hemoglobin levels and associations with other disease parameters in rheumatoid arthritis patients: evidence from the CORRONA registry. Clin Exp Rheumatol 27:560-566
21. Raj DS (2009) Role of interleukin-6 in the anemia of chronic disease. Semin Arthritis Rheum 38:382-388
22. Farr M, Scott DL, Constable TJ et al (1983) Thrombocytosis of active rheumatoid disease. Ann Rheum Dis 42:545-549 (Pubitemid 13016027)
23. Ertenli I, Haznedaroglu IC, Kiraz S et al (1996) Cytokines affecting megakaryocytopoiesis in rheumatoid arthritis with thrombocytosis. Rheumatol Int 16:5-8 (Pubitemid 26168313)
24. Aletaha D, Funovits J, Keystone EC et al (2007) Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients. Arthritis Rheum 56:3226-3235 (Pubitemid 47585417)
25. Grigor C, Capell H, Stirling A et al (2004) Effect of a treatment strategy of tight control for rheumatoid arthritis (the TICORA study): a single-blind randomised controlled trial. Lancet 364:263-269 (Pubitemid 38942816)
26. Rantalaiho V, Korpela M, Laasonen L et al (2010) Early combination disease-modifying antirheumatic drug therapy and tight disease control improve long-term radiologic outcome in patients with early rheumatoid arthritis: the 11-year results of the Finnish Rheumatoid Arthritis Combination Therapy trial. Arthritis Res Ther 12:R122
27. van der Kooij SM, de Vries-Bouwstra JK, Goekoop-Ruiterman YP et al (2007) Limited efficacy of conventional DMARDs after initial methotrexate failure in patients with recent onset rheumatoid arthritis treated according to the disease activity score. Ann Rheum Dis 66:1356-1362 (Pubitemid 47492481)
28. van der Helm-van Mil AH, Verpoort KN, Breedveld FC (2005) Antibodies to citrullinated proteins and differences in clinical progression of rheumatoid arthritis. Arthritis Res Ther 7:R949-R958
29. Jawaheer D, Maranian P, Park G et al (2010) Disease progression and treatment responses in a prospective DMARD-naive seropositive early rheumatoid arthritis cohort: does gender matter? J Rheumatol 37:2475-2485
30. Papadopoulos NG, Alamanos Y, Voulgari PV et al (2005) Does cigarette smoking influence disease expression, activity and severity in early rheumatoid arthritis patients? Clin Exp Rheumatol 23:861-866 (Pubitemid 43040515)